Literature DB >> 22396542

Goodpasture antigen-binding protein/ceramide transporter binds to human serum amyloid P-component and is present in brain amyloid plaques.

Chiara Mencarelli1, Gerard H Bode, Mario Losen, Mahesh Kulharia, Peter C Molenaar, Robert Veerhuis, Harry W M Steinbusch, Marc H De Baets, Gerry A F Nicolaes, Pilar Martinez-Martinez.   

Abstract

Serum amyloid P component (SAP) is a non-fibrillar glycoprotein belonging to the pentraxin family of the innate immune system. SAP is present in plasma, basement membranes, and amyloid deposits. This study demonstrates, for the first time, that the Goodpasture antigen-binding protein (GPBP) binds to human SAP. GPBP is a nonconventional Ser/Thr kinase for basement membrane type IV collagen. Also GPBP is found in plasma and in the extracellular matrix. In the present study, we demonstrate that GPBP specifically binds SAP in its physiological conformations, pentamers and decamers. The START domain in GPBP is important for this interaction. SAP and GPBP form complexes in blood and partly colocalize in amyloid plaques from Alzheimer disease patients. These data suggest the existence of complexes of SAP and GPBP under physiological and pathological conditions. These complexes are important for understanding basement membrane, blood physiology, and plaque formation in Alzheimer disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22396542      PMCID: PMC3340266          DOI: 10.1074/jbc.M111.299545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  51 in total

1.  Mapping protein-protein interaction domains using ordered fragment ladder far-western analysis of hexahistidine-tagged fusion proteins.

Authors:  R R Burgess; T M Arthur; B C Pietz
Journal:  Methods Enzymol       Date:  2000       Impact factor: 1.600

2.  Evidence for the binding of human serum amyloid P component to Clq and Fab gamma.

Authors:  C L Bristow; R J Boackle
Journal:  Mol Immunol       Date:  1986-10       Impact factor: 4.407

3.  Effect of divalent metal ions and pH upon the binding reactivity of human serum amyloid P component, a C-reactive protein homologue, for zymosan. Preferential reactivity in the presence of copper and acidic pH.

Authors:  L A Potempa; B M Kubak; H Gewurz
Journal:  J Biol Chem       Date:  1985-10-05       Impact factor: 5.157

4.  Amyloid P component is not present in the glomerular basement membrane in Alport-type hereditary nephritis.

Authors:  T Melvin; Y Kim; A F Michael
Journal:  Am J Pathol       Date:  1986-12       Impact factor: 4.307

5.  Amyloid P-component in human glomerular basement membrane. Abnormal patterns of immunofluorescent staining in glomerular disease.

Authors:  R F Dyck; D J Evans; C M Lockwood; A J Rees; D Turner; M B Pepys
Journal:  Lancet       Date:  1980-09-20       Impact factor: 79.321

6.  Calcium-dependent aggregation of human serum amyloid P component.

Authors:  M L Baltz; F C De Beer; A Feinstein; M B Pepys
Journal:  Biochim Biophys Acta       Date:  1982-02-18

7.  Agglutination of complement-coated erythrocytes by serum amyloid P-component.

Authors:  C L Hutchcraft; H Gewurz; B Hansen; R F Dyck; M B Pepys
Journal:  J Immunol       Date:  1981-03       Impact factor: 5.422

8.  The structure and binding characteristics of serum amyloid protein (9.5S alpha 1-glycoprotein).

Authors:  R H Painter; I De Escallón; A Massey; L Pinteric; S B Stern
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

9.  Ca2+-mediated association of human serum amyloid P component with heparan sulfate and dermatan sulfate.

Authors:  H Hamazaki
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Fibronectin and C4-binding protein are selectively bound by aggregated amyloid P component.

Authors:  F C de Beer; M L Baltz; S Holford; A Feinstein; M B Pepys
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  12 in total

1.  The Association Between Plasma Ceramides and Sphingomyelins and Risk of Alzheimer's Disease Differs by Sex and APOE in the Baltimore Longitudinal Study of Aging.

Authors:  Michelle M Mielke; Norman J Haughey; Dingfen Han; Yang An; Veera Venkata Ratnam Bandaru; Constantine G Lyketsos; Luigi Ferrucci; Susan M Resnick
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

2.  Tenascin-C Is Associated with Cored Amyloid-β Plaques in Alzheimer Disease and Pathology Burdened Cognitively Normal Elderly.

Authors:  Zhiping Mi; Willi Halfter; Eric E Abrahamson; William E Klunk; Chester A Mathis; Elliott J Mufson; Milos D Ikonomovic
Journal:  J Neuropathol Exp Neurol       Date:  2016-07-21       Impact factor: 3.685

3.  Embryo implantation triggers dynamic spatiotemporal expression of the basement membrane toolkit during uterine reprogramming.

Authors:  Celestial R Jones-Paris; Sayan Paria; Taloa Berg; Juan Saus; Gautam Bhave; Bibhash C Paria; Billy G Hudson
Journal:  Matrix Biol       Date:  2016-09-10       Impact factor: 11.583

4.  Unicellular ancestry and mechanisms of diversification of Goodpasture antigen-binding protein.

Authors:  Carl Darris; Fernando Revert; Francisco Revert-Ros; Roberto Gozalbo-Rovira; Andrew Feigley; Aaron Fidler; Ernesto Lopez-Pascual; Juan Saus; Billy G Hudson
Journal:  J Biol Chem       Date:  2018-10-30       Impact factor: 5.157

5.  Early activation of nSMase2/ceramide pathway in astrocytes is involved in ischemia-associated neuronal damage via inflammation in rat hippocampi.

Authors:  LiZe Gu; BaoSheng Huang; Wei Shen; Li Gao; ZhengZheng Ding; HuiWen Wu; Jun Guo
Journal:  J Neuroinflammation       Date:  2013-09-03       Impact factor: 8.322

6.  Ceramides predict verbal memory performance in coronary artery disease patients undertaking exercise: a prospective cohort pilot study.

Authors:  Mahwesh Saleem; Veera V Ratnam Bandaru; Nathan Herrmann; Walter Swardfager; Michelle M Mielke; Paul I Oh; Prathiba Shammi; Alexander Kiss; Norman J Haughey; Randal Rovinski; Krista L Lanctôt
Journal:  BMC Geriatr       Date:  2013-12-12       Impact factor: 3.921

Review 7.  Sphingolipids as prognostic biomarkers of neurodegeneration, neuroinflammation, and psychiatric diseases and their emerging role in lipidomic investigation methods.

Authors:  Daan van Kruining; Qian Luo; Gerhild van Echten-Deckert; Michelle M Mielke; Andrew Bowman; Shane Ellis; Tiago Gil Oliveira; Pilar Martinez-Martinez
Journal:  Adv Drug Deliv Rev       Date:  2020-04-28       Impact factor: 15.470

8.  Ceramide analog [18F]F-HPA-12 detects sphingolipid disbalance in the brain of Alzheimer's disease transgenic mice by functioning as a metabolic probe.

Authors:  Simone M Crivelli; Daan van Kruining; Qian Luo; Jo A A Stevens; Caterina Giovagnoni; Andreas Paulus; Matthias Bauwens; Dusan Berkes; Helga E de Vries; Monique T Mulder; Jochen Walter; Etienne Waelkens; Rita Derua; Johannes V Swinnen; Jonas Dehairs; Felix M Mottaghy; Mario Losen; Erhard Bieberich; Pilar Martinez-Martinez
Journal:  Sci Rep       Date:  2020-11-09       Impact factor: 4.379

9.  CERTL reduces C16 ceramide, amyloid-β levels, and inflammation in a model of Alzheimer's disease.

Authors:  Simone M Crivelli; Qian Luo; Jo A A Stevens; Caterina Giovagnoni; Daan van Kruining; Gerard Bode; Sandra den Hoedt; Barbara Hobo; Anna-Lena Scheithauer; Jochen Walter; Monique T Mulder; Christopher Exley; Matthew Mold; Michelle M Mielke; Helga E De Vries; Kristiaan Wouters; Daniel L A van den Hove; Dusan Berkes; María Dolores Ledesma; Joost Verhaagen; Mario Losen; Erhard Bieberich; Pilar Martinez-Martinez
Journal:  Alzheimers Res Ther       Date:  2021-02-17       Impact factor: 6.982

Review 10.  Ceramide Transfer Protein (CERT): An Overlooked Molecular Player in Cancer.

Authors:  Long Hoa Chung; Da Liu; Xin Tracy Liu; Yanfei Qi
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.